PRQR

#3650
ProQR Therapeutics N.V. Ordinary Shares
1.95 USD
+8.33%
부문: 헬스케어
베이스: USD
수익 통화: USD
일일 변동 비율
1.91
1.95
년간 변동
1.12
3.10
일일 변동
+8.33%
월간 변동
+5.98%
6달 변화
-21.69%
년간 변동율
+65.25%
이전 종가
1.80
Open
1.92
Bid
Ask
Low
1.91
High
1.95
양
60
Open full chart

Financials

Overview 성명 Statistics
Quarterly Annual
  • Market Capitalization 205.45 M
  • Employee 187
  • Founded 2012
  • CEO Daniel A. de Boer
  • Website www.proqr.com
  • Headquarter Netherlands
  • FIGI UNKNOWN
  • Industry Technology

ProQR Therapeutics N.V

ProQR Therapeutics NV is a Dutch biotechnology company based in Leiden, the Netherlands, with a presence in Cambridge, Massachusetts, US. The company was funded in 2012 by chief executive officer Daniel A. de Boer. It specializes in the development of RNA therapeutics using its RNA editing platform technology called Axiomer.

뉴스